Haleon introduces corporate identity nationwide in Nigeria, products unchanged
Haleon, the consumer health company formed after its demerger from GSK on July 18, 2022, is rolling out its corporate identity across Nigeria in a phased transition. Trusted brands including Panadol, Sensodyne, Macleans, Otrivin, Voltaren, Cac 1000 and Andrews Liver Salts remain unchanged in formulation, quality and effectiveness. The rebranding is a labeling update only, with Haleon emphasizing transparency and consumer confidence through its partnership with Fidson Healthcare for local production. Currently, Panadol Extra 100s and Panadol Pain & Fever 100s are being supplied to the market under the Haleon identity. Sensodyne Rapid Action will bear the Haleon logo from mid-June 2026, followed by Andrews Liver Salts later this year. In due course, Otrivin, Voltaren, Cac 1000, Macleans and the wider Sensodyne portfolio will also transition. Haleon says the change ensures continued access to high-quality everyday health products at pharmacies, supermarkets and other retail outlets nationwide. Himanshu Raj, Haleon General Manager for Sub-Saharan Africa, stated the move reassures consumers that the products they rely on stay the same while supporting local manufacturing. Will you continue purchasing these familiar brands now carrying the Haleon name, or consider alternatives based on the updated packaging?